Handbook of multiple sclerosis
著者
書誌事項
Handbook of multiple sclerosis
(Neurological disease and therapy, 53)
M. Dekker, c2001
3rd ed.
- hc : alk. paper
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options.
Analyzes recent developments in the natural history, immunopathology, lesion evolution, and therapy affecting MS treatment-including up-to-date research results from experimental therapies with t-cell vaccines, oral myelin, and monoclonal antibodies!
Summarizing previous breakthroughs and pointing the way toward future research, the Handbook of Multiple Sclerosis, Third Edition
provides a historical summary of the disease and examines the epidemiology and genetics of MS, including new evidence for and against an infectious etiology
investigates virus-induced demyelination, emphasizing models such as canine distemper (CDV), corona, visna, and herpes simplex viruses; the semliki forest virus (SFV); and animal models of autoimmune demyelination
notes the role of magnetic resonance imaging (MRI) in diagnosis, prognosis, natural history, and as a guide to therapy
explores the growing evidence for axonal damage as a major cause of disability in MS
summarizes the natural history of MS and delineates factors influencing exacerbations and progression of the disease
assesses current clinical and biological prognostic indicators for accurate diagnoses of MS as opposed to other idiopathic inflammatory demyelinating diseases (IIDDs) and evaluates the growing number of therapies for treating MS
and more!
目次
Etiopathogenesis
The History of Multiple Sclerosis
W. I. McDonald
The Epidemiology of Multiple Sclerosis
William Pryse-Phillips and Fiona Costello
The Genetics of Multiple Sclerosis
Jan Hillert and Thomas Masterman
Experimental Models of Virus-Induced Demyelination
Mauro C. Dal Canto
Evidence for a Viral Etiology of Multiple Sclerosis
Stuart D. Cook
Experimental Models of Autoimmune Demyelination
Fred D. Lublin
Evidence for Immunopathogenesis
Ute Traugott
Autoantibodies in Demyelinating Disease
Anne H. Cross, Jeri-Anne Lyons, and John L. Trotter
Clinical Pathologic Features
Clinical Features
Aaron E. Miller
Cognitive Impairment in Multiple Sclerosis
Jill S. Fischer
Loss and Restoration of Impulse Conduction in Disorders of Myelin
Stephen G. Waxman
Pathology of Multiple Sclerosis
John W. Prineas
Axonal Injury in Multiple Sclerosis
Carl Bjartmar and Bruce D. Trapp
Cerebrospinal Fluid
John N. Whitaker, Khurram Bashir, and Etty N. Benveniste
Laboratory Tests: Evoked Potentials
Marc R. Nuwer
Neuroimaging and the Use of Magnetic Resonance in Multiple Sclerosis
Lael A. Stone, Nancy Richert, and Henry McFarland
Therapeutic Considerations
The Natural History of Multiple Sclerosis
Sandra Vukusic and Christian Confavreux
Prognostic Factors in Multiple Sclerosis
Orhun H. Kantarci and Brian G. Weinshenker
Therapeutic Considerations: Rating Scales
Richard Rudick, Brian Weinshenker, and Gary Cutter
Therapeutic Considerations: Treatment of the Acute Exacerbation
Raymond Troiano
Interferon- -1b: Prophylactic Therapy in Multiple Sclerosis
Kenneth P. Johnson and Peter A. Calabresi
Therapeutic Considerations: Prophylactic Therapy with Interferon- -1a
Lawrence Jacobs
Prophylactic Therapy-Glatiramer Acetate (Copaxone (R))
Hillel Panitch
Treatment of Multiple Sclerosis with Intravenous Immunoglobulin
P. Rudge
Immunosuppressive Drugs
Mariko Kita and Donald E. Goodkin
Treatment of Multiple Sclerosis: Bone Marrow Reconstitution, Total Lymphoid Irradiation, and Plasma Exchange
George P. A. Rice
Symptomatic Therapy
Randall T. Schapiro
Symptomatic Treatment and Rehabilitation in Multiple Sclerosis
Charles R. Smith and Labe Scheinberg
Experimental Therapies with T-Cell Vaccines, Oral Myelin, and Monoclonal Antibodies in Multiple Sclerosis
Suprabha Bhat and Jerry S. Wolinsky
Future Immunotherapies
Christine Rohowsky-Kochan
「Nielsen BookData」 より